| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $11.1M | +62.6% |
| SG&A Expense | $8.8M | +3.8% |
| Operating Income | -$19.9M | -29.9% |
| Pre-tax Income | -$19.4M | -32.9% |
| Income Tax | $0 | — |
| Net Income | -$19.4M | -32.9% |
| EPS (Basic) | -$0.73 | -1.4% |
| EPS (Diluted) | -$0.73 | -1.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.4M | -85.3% |
| Current Assets | $2.8M | -83.5% |
| Total Assets | $3.3M | -80.9% |
| Total Liabilities | $1.6M | +35.8% |
| Stockholders' Equity | $1.7M | -89.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$14.5M | -19.7% |
| Capital Expenditures | $201K | -21.5% |
| Investing Cash Flow | -$201K | +21.5% |
| Financing Cash Flow | $866K | -96.5% |
| Free Cash Flow | -$14.7M | -18.8% |